ATRICURE INC (ATRC)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ATRC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ATRC | Chair; Director | 61 | [] | ["Audit","Compensation","Nominating and Corporate Governance Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GILD | Executive Vice President, Corporate Affairs and General Counsel | 58 | ["more than 25-year career in legal counsel", "experience in global mergers and acquisitions", "governance and litigation", "Juris Doctor degree from Boston University School of Law", "bachelor\u2019s degree in mathematics from the University of Pennsylvania", "Expertise in Corporate Affairs and Legal Organization", "Oversaw litigation related to TAF patents", "Promotes inclusive work environment"] | ["Gilead Leadership Organization of Black Employees (GLOBE)"] | 2023 |
Biography sourced from the proxy statement filing.
Ms. Telman has served as one of our directors since June 2021. From 2022 to 2025, Ms. Telman was Executive Vice President, Corporate Affairs and General Counsel for Gilead Sciences, Inc., a leading biopharmaceutical company, where she oversaw legal, government affairs, policy, and public affairs and served as Corporate Secretary. Previously, Ms. Telman served as Executive Vice President and General Counsel for Organon & Co., a global healthcare company formed in March 2021 through a spin off from Merck to focus on improving the health of women throughout their lives. Ms. Telman helped lead the separation work that created a standalone company serving more than 140 markets with more than 60 medicines and products across a range of therapeutic areas. Ms. Telman held senior roles at Sorrento Therapeutics, Johnson Controls International plc, Abbott Laboratories and The Boeing Company. She began her legal career at Winston and Strawn LLP. Ms. Telman currently serves as a director of the Chicago Humanities Festival. Ms. Telman holds a B.A. in Mathematics from the University of Pennsylvania and J.D. from Boston University School of Law. Ms. Telman's extensive experience in legal affairs, mergers, acquisitions and divestitures, environmental, health and safety, human capital management, regulatory compliance and governance roles within healthcare companies are beneficial to the management team and the Board.